https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/rtgpwexe/cover_janfeb25.jpg
Ophthalmology Managementhttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/dvsf1uun/cover.jpg
Contact Lens Spectrumhttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/npjdtl1w/cp_november_cover.jpg
Corneal Physicianhttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/i5xfuxqu/eb_0125_janfeb-cover.jpg
Eyecare Businesshttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/i1udssrm/gp_cover_nov24.jpg
Glaucoma Physicianhttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/mvqdq2hc/nrp_cover_october_2024.jpg
New Retinal Physicianhttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/1hxbzi3g/op_0125_cover.jpg
Ophthalmic Professionalhttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/53bbqpwy/screenshot-2024-12-16-at-11437-pm.png
Optometric Managementhttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/aqbjxwjw/pp-cover.jpg
Presbyopia Physicianhttps://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/cdbhnbx2/cover_janfeb25_web.jpg
Retinal PhysicianNew RAC verteporfin audits are being challenged
A result of excessive vitreous base shaving?
Four therapies from which to choose.
Ocriplasmin: two decades of commitment to a concept.
What clinical and economic evidence exists to support ILM peeling?
Recurrence of hemorrhage after vitrectomy can be a troublesome complication.
Our coverage of the 2012 Retinal Physician Symposium continues.
FDA approves Lucentis for DME; Could an eyedrop treat wet AMD; LCA-causing gene is Isolated; Five-year follow-up on Lucentis for RVO; and more
An ocular oncologist offers his clinical opinions.
To peel or not to peel — That is the question